Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles

Journal of Virology

Volumn 73, Issue 9, 1999, Pages 7565-7573

  McNeal, Monica M ^a   Rae, Mary N ^a   Bean, Judy A ^a   Ward, Richard L ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI ENTEROTOXIN; IMMUNOLOGICAL ADJUVANT; ROTAVIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; ESCHERICHIA COLI; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSTIMULATION; INTRANASAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; ROTAVIRUS; VIRUS INFECTION;

EID: 0032855417     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.9.7565-7573.1999     Document Type: Article

References (40)

1. Bass, D. M. 1997. Interferon gamma and interleukin 1, but not interferon alfa, inhibit rotavirus entry into human intestinal cell lines. Gastroenterology 113:81-89.
2. Bernstein, D. I., R. I. Glass, G. Rodgers, B. L. Davidson, and D. A. Sack for the U.S. Rotavirus Vaccine Efficacy Group. 1995. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in U.S. children. J. Am. Med. Assoc. 273:1191-1196.
3. Bernstein, D. I., V. E. Smith, D. S. Sander, K. A. Pax, G. M. Schiff, and R. L. Ward. 1990. Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J. Infect. Dis. 162:1055-1062.
4. Bromander, A. K., M. Kjerrulf, J. Holmgren, and N. Lycke. 1993. Cholera toxin enhances alloantigen presentation by cultured intestinal epithelial cells. Scand. J. Immunol. 37:452-458.
5. Clark, H. F., P. A. Offit, R. W. Ellis, J. J. Eiden, D. Krah, A. R. Shaw, M. Pichichero, J. J. Treanor, F. E. Borian, L. M. Bell, and S. A. Plotkin. 1996. The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants. J. Infect. Dis. 174:S73-S80.
6. Clements, J. D., and R. A. Finkelstein. 1979. Isolation and characterization of homogenous heat-labile enterotoxins with high specific activity from Escherichia coli cultures. Infect. Immun. 24:760-769.
7. Coulson, B. S., K. Grimwood, I. L. Hudson, G. L. Barnes, and R. F. Bishop. 1992. Role of coproantibody in clinical protection of children during reinfection with rotavirus. 30:1678-1684.
8. Dickinson, B. L., and J. D. Clements. 1995. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect. Immun. 63:1617-1623.
9. Dickinson, B. L., and J. D. Clements. 1996. Use of Escherichia coli heat-labile enterotoxin as an oral adjuvant, p. 73-87. In H. Kiyono, P. L. Ogra, and J. R. McGhee (ed.), Mucosal vaccines. Academic Press, Inc., San Diego, Calif.
10. Feng, N., J. W. Burns, L. Bracey, and H. B. Greenberg. 1994. Comparison of the mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with homologous or heterologous rotaviruses. J. Virol. 68:7766-7773.
11. Franco, M. A., and H. B. Greenberg. 1995. Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J. Virol. 69:7800-7806.
12. + T cells can mediate almost complete short-term and partial long-term immunity to rotavirus in mice. J. Virol. 71:4165-4170.
13. Groene, W. S., and R. D. Shaw. 1992. Psoralen preparation of antigenically intact noninfectious rotavirus particles. J. Virol. Methods 38:93-102.
14. + T lymphocytes. Immunol. Rev. 151:31-49.
15. Hornquist, E., and N. Lycke. 1993. Cholera toxin adjuvant greatly promotes antigen priming of T cells. Eur. J. Immunol. 23:2136-2143.
16. Kitamura, D., J. Roes, R. Kühn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 350:423-426.
17. Knowlton, D. R., D. M. Spector, and R. L. Ward. 1991. Development of an improved method for measuring neutralizing antibody to rotavirus. J. Virol. Methods 33:127-134.
18. Lanata, C. F., K. Midthun, R. E. Black, B. Butron, A. Huapaya, M. E. Penny, G. Ventura, A. Gil, M. Jett-Goheen, and B. L. Davidson. 1996. Safety, immunogenicity, and protective efficacy of one and three doses of tetravalent rhesus rotavirus vaccine in infants in Lima, Peru. J. Infect. Dis. 174:268-275.
19. Liu, M. A. 1998. Vaccine developments. Nat. Med. 4:515-519.
20. Lycke, N., U. Karlsson, A. Sjolander, and K.-E. Magnusson. 1991. The adjuvant effect of cholera toxin is associated with an increased intestinal permeability for luminal antigens. Scand. J. Immunol. 33:691-698.
21. Matson, D. O., M. L. O'Ryan, I. Herrera, L. K. Pickering, and M. K. Estes. 1993. Fecal antibody responses to symptomatic and asymptomatic rotavirus infections. J. Infect. Dis. 167:577-583.
22. McDermott, M. R., and J. Bienenstock. 1979. Evidence for a common mucosal immunologic system. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J. Immunol. 122:1892-1898.
23. + cells in resolution of rotavirus infection and protection against reinfection in mice. Virology 214:387-397.
24. McNeal, M. M., R. L. Broome, and R. L. Ward. 1994. Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination. Virology 204:642-650.
25. McNeal, M. M., M. N. Rae, M. E. Conner, and R. L. Ward. 1998. Stimulation at local immunity and protection in mice by intramuscular immunization with triple- or double-layered rotavirus particles and QS-21. Virology 243: 158-166.
26. McNeal, M. M., M. N. Rae, and R. L. Ward. 1997. Evidence that resolution of rotavirus infection in mice is due to both CD4 and CD8 cell-dependent activities. J. Virol. 71:8735-8742.
27. McNeal, M. M., J. F. Sheridan, and R. L. Ward. 1992. Active protection against rotavirus infection of mice following intraperitoneal immunization. Virology 191:150-157.
28. McNeal, M. M., and R. L. Ward. 1995. Long-term production of rotavirus antibody and protection against reinfection following a single infection of neonatal mice with murine rotavirus. Virology 211:474-480.
29. Mosmann, T. R., and R. L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretions lead to different functional properties. Annu. Rev. Immunol. 7:145-174.
30. Oldham, G., J. C. Bridger, C. J. Howard, and K. R. Parsons. 1993. In vivo role of lymphocyte subpopulation in the control of virus excretion and mucosa antibody responses of cattle infected with rotavirus. J. Virol. 67: 5012-5019.
31. O'Neal, C. M., J. D. Clements, M. K. Estes, and M. E. Conner. 1998. Rotavirus 2/6 viruslike particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge. J. Virol. 72:3390-3393.
32. O'Neal, C. M., S. E. Crawford, M. K. Estes, and M. E. Conner. 1997. Rotavirus virus-like particles administered mucosally induce protective immunity. J. Virol. 71:8707-8717.
33. Rennels, M. B., R. I. Glass, P. H. Dennehy, D. I. Bernstein, M. E. Pichichero, E. T. Zito, M. E. Mack, B. L. Davidson, and A. Z. Kapikinn, for the U.S. Rotavirus Vaccine Efficacy Group. 1996. Safety and efficacy of high dose rhesus-human reassortant rotavirus vaccines: Report of the national multicenter trial. Pediatrics 97:7-13.
34. Santosham, M., G. W. Letson, M. Wolff, R. Reid, S. Gahagan, R. Adams, C. Callahan, R. B. Sack, and A. Z. Kapikinn. 1991. A field study of the safety and efficacy of two candidate vaccines in a Native American population. J. Infect. Dis. 163:483-487.
35. Snider, D. P., J. S. Marshall, M. H. Perdue, and H. Liang. 1994. Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin. J. Immunol. 53:647-657.
36. Vesikari, T. 1993. Clinical trials of live, oral rotavirus vaccines: the Finnish experience. Vaccine 11:255-261.
37. Ward, R. L., M. M. McNeal, and J. F. Sheridan. 1990. Development of an adult mouse model for studies on protection against rotavirus. J. Virol. 64:5070-5075.
38. Ward, R. L., M. M. McNeal, and J. F. Sheridan. 1992. Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody. Virology 188:57-66.
39. Weisz-Carrington, P., M. E. Roux, M. McWilliams, J. M. Phillips-Quagliata, and M. E. Lamm. 1979. Organ and isotype distribution of plasma cells producing specific antibody after oral immunization: evidence for a generalized secretory immune system. J. Immunol. 123:1705-1708.
40. Xu-Amano, J., R. J. Jackson, K. Fujihashi, H. Kiyono, H. F. Staats, and J. R. McGhee. 1994. Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin. Vaccine 12:903-911.